Clinical Trial Update: Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of EDI048 in a Cryptosporidium infection model in healthy adults; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptosporidiosis

Drugs mentioned

• EDI048

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cryptosporidiosis | Phase 2 | Status: RECRUITING